RecruitingNot ApplicableNCT04650880

Effect of Vitamin D on Ovulation Rate in Women With Polycystic Ovary Syndrome

A Randomized Double-blind Controlled Trial on the Effect of Vitamin D on Ovulation Rate of Women With Polycystic Ovary Syndrome


Sponsor

The University of Hong Kong

Enrollment

220 participants

Start Date

Jan 26, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized double-blind controlled trial on the effect of vitamin D supplementation to assess the ovulation rate of women with polycystic ovary syndrome (PCOS) and other reproductive, endocrine and metabolic outcomes after one year of treatment.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Inclusion Criteria5

  • Premenopausal
  • Aged 18-40 years
  • Irregular long menstrual cycles (\>35 days)
  • PCOS according to the Rotterdam criteria
  • Agree for transvaginal ultrasound

Exclusion Criteria8

  • Use of hormonal medication (including contraception) within 3 months prior to study inclusion, except the use of a progestogen to induce withdrawal bleeding every 3 months
  • History of any medical condition or medications that may predispose to vitamin D sensitivity, altered vitamin D metabolism and/ or hypercalcemia, including active tuberculosis or current therapy for tuberculosis, sarcoidosis, history of renal/ ureteral stones, parathyroid disease, renal or liver failure or current use of anti-convulsants
  • Use of insulin-sensitizing drugs, lipid lowering drugs or anti-hypertensive
  • Anticipated to use the above medications in the coming one year
  • Known type 2 diabetes mellitus
  • Refusal to join the study
  • Abnormal blood calcium level
  • For those on supplements, we asked them to stop their own supplements.

Interventions

DIETARY_SUPPLEMENTVitamin D

Vitamin D supplementation

OTHERPlacebo

Placebo tablets with the same external appearance


Locations(3)

Kwong Wah Hospital

Hong Kong, Hong Kong

Princess Margaret Hospital

Hong Kong, Hong Kong

Queen Mary Hospital, University of Hong Kong

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04650880


Related Trials